Edwards Lifesciences Corporation Net Cash Provided by (Used in) Operating Activities, Continuing Operations
Edwards Lifesciences Corporation (EW) reported Net Cash Provided by (Used in) Operating Activities, Continuing Operations of $636.80 million for the 9-month period ending 2017-09-30, per its 10-Q filed 2017-10-27.
Discontinued › Cash Flow › Operating Activities
us-gaap:NetCashProvidedByUsedInOperatingActivitiesContinuingOperations · last filed 2017-10-27
- Edwards Lifesciences Corporation net cash provided by (used in) operating activities, continuing operations for the quarter ending 2017-09-30 was $310.80M, a 50.95% increase year-over-year.
- Edwards Lifesciences Corporation net cash provided by (used in) operating activities, continuing operations for the quarter ending 2017-06-30 was $197.70M, a 3.89% increase year-over-year.
- Edwards Lifesciences Corporation net cash provided by (used in) operating activities, continuing operations for the quarter ending 2017-03-31 was $128.30M, a 19.79% increase year-over-year.
- Edwards Lifesciences Corporation net cash provided by (used in) operating activities, continuing operations for the quarter ending 2016-12-31 was $201.10M, a 93.74% increase year-over-year.
- Edwards Lifesciences Corporation net cash provided by (used in) operating activities, continuing operations for fiscal 2016 was $704.40M, a 28.14% increase from fiscal 2015.
- Edwards Lifesciences Corporation net cash provided by (used in) operating activities, continuing operations for fiscal 2015 was $549.70M, a 46.23% decline from fiscal 2014.
- Edwards Lifesciences Corporation net cash provided by (used in) operating activities, continuing operations for fiscal 2014 was $1.02B, a 116.27% increase from fiscal 2013.
- Edwards Lifesciences Corporation net cash provided by (used in) operating activities, continuing operations for fiscal 2013 was $472.70M, a 30.54% increase from fiscal 2012.
| Period end | Net Cash Provided by (Used in) Operating Activities, Continuing Operations 3 month | Net Cash Provided by (Used in) Operating Activities, Continuing Operations 3 month as first filed | Net Cash Provided by (Used in) Operating Activities, Continuing Operations 6 month | Net Cash Provided by (Used in) Operating Activities, Continuing Operations 6 month as first filed | Net Cash Provided by (Used in) Operating Activities, Continuing Operations 9 month | Net Cash Provided by (Used in) Operating Activities, Continuing Operations 9 month as first filed | Net Cash Provided by (Used in) Operating Activities, Continuing Operations 12 month | Net Cash Provided by (Used in) Operating Activities, Continuing Operations 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2017-09-30 | $310.80M derived: 10-Q 9 month − 10-Q 6 month · filed 2017-10-27 | $508.50M derived: sum of 2 quarters · filed 2017-10-27 | $636.80M 10-Q · filed 2017-10-27 | $837.90M derived: sum of 4 quarters · filed 2017-10-27 | ||||
| 2017-06-30 | $197.70M derived: 10-Q 6 month − 10-Q 3 month · filed 2017-07-28 | $326.00M 10-Q · filed 2017-07-28 | $527.10M derived: sum of 3 quarters · filed 2017-07-28 | $733.00M derived: sum of 4 quarters · filed 2017-10-27 | ||||
| 2017-03-31 | $128.30M 10-Q · filed 2017-04-28 | $329.40M derived: sum of 2 quarters · filed 2017-04-28 | $535.30M derived: sum of 3 quarters · filed 2017-10-27 | $725.60M derived: sum of 4 quarters · filed 2017-10-27 | ||||
| 2016-12-31 | $201.10M derived: 10-K 12 month − 10-Q 9 month · filed 2017-02-17 | $407.00M derived: sum of 2 quarters · filed 2017-10-27 | $597.30M derived: sum of 3 quarters · filed 2017-10-27 | $704.40M 10-K · filed 2017-02-17 | ||||
| 2016-09-30 | $205.90M derived: 10-Q 9 month − 10-Q 6 month · filed 2017-10-27 | $396.20M derived: sum of 2 quarters · filed 2017-10-27 | $503.30M 10-Q · filed 2017-10-27 | $607.10M derived: sum of 4 quarters · filed 2017-10-27 | ||||
| 2016-06-30 | $190.30M derived: 10-Q 6 month − 10-Q 3 month · filed 2017-07-28 | $297.40M 10-Q · filed 2017-07-28 | $401.20M derived: sum of 3 quarters · filed 2017-07-28 | $603.70M derived: sum of 4 quarters · filed 2017-07-28 | ||||
| 2016-03-31 | $107.10M 10-Q · filed 2017-04-28 | $210.90M derived: sum of 2 quarters · filed 2017-04-28 | $413.40M derived: sum of 3 quarters · filed 2017-04-28 | $583.50M derived: sum of 4 quarters · filed 2017-04-28 | ||||
| 2015-12-31 | $103.80M derived: 10-K 12 month − 10-Q 9 month · filed 2017-02-17 | $306.30M derived: sum of 2 quarters · filed 2017-02-17 | $476.40M derived: sum of 3 quarters · filed 2017-02-17 | $549.70M 10-K · filed 2017-02-17 | ||||
| 2015-09-30 | $202.50M derived: 10-Q 9 month − 10-Q 6 month · filed 2016-10-28 | $372.60M derived: sum of 2 quarters · filed 2016-10-28 | $445.90M 10-Q · filed 2016-10-28 | $539.10M derived: sum of 4 quarters · filed 2017-02-17 | ||||
| 2015-06-30 | $170.10M derived: 10-Q 6 month − 10-Q 3 month · filed 2016-07-29 | $243.40M 10-Q · filed 2016-07-29 | $336.60M derived: sum of 3 quarters · filed 2017-02-17 | $348.80M derived: sum of 4 quarters · filed 2017-02-17 | ||||
| 2015-03-31 | $73.30M 10-Q · filed 2016-04-29 | $166.50M derived: sum of 2 quarters · filed 2017-02-17 | $178.70M derived: sum of 3 quarters · filed 2017-02-17 | $956.70M derived: sum of 4 quarters · filed 2017-02-17 | ||||
| 2014-12-31 | $93.20M derived: 10-K 12 month − 10-Q 9 month · filed 2017-02-17 | $105.40M derived: sum of 2 quarters · filed 2017-02-17 | $883.40M derived: sum of 3 quarters · filed 2017-02-17 | $1.02B 10-K · filed 2017-02-17 | ||||
| 2014-09-30 | $12.20M derived: 10-Q 9 month − 10-Q 6 month · filed 2015-10-29 | $790.20M derived: sum of 2 quarters · filed 2015-10-29 | $929.10M 10-Q · filed 2015-10-29 | $1.04B derived: sum of 4 quarters · filed 2016-02-19 | ||||
| 2014-06-30 | $778.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2015-07-29 | $916.90M 10-Q · filed 2015-07-29 | $1.03B derived: sum of 3 quarters · filed 2016-02-19 | $1.16B derived: sum of 4 quarters · filed 2016-02-19 | ||||
| 2014-03-31 | $138.90M 10-Q · filed 2015-04-29 | $250.20M derived: sum of 2 quarters · filed 2016-02-19 | $382.40M derived: sum of 3 quarters · filed 2016-02-19 | $510.50M derived: sum of 4 quarters · filed 2016-02-19 | ||||
| 2013-12-31 | $111.30M derived: 10-K 12 month − 10-Q 9 month · filed 2016-02-19 | $243.50M derived: sum of 2 quarters · filed 2016-02-19 | $371.60M derived: sum of 3 quarters · filed 2016-02-19 | $472.70M 10-K · filed 2016-02-19 | ||||
| 2013-09-30 | $132.20M derived: 10-Q 9 month − 10-Q 6 month · filed 2014-10-31 | $260.30M derived: sum of 2 quarters · filed 2014-10-31 | $361.40M 10-Q · filed 2014-10-31 | $476.10M derived: sum of 4 quarters · filed 2015-02-20 | ||||
| 2013-06-30 | $128.10M derived: 10-Q 6 month − 10-Q 3 month · filed 2014-08-04 | $229.20M 10-Q · filed 2014-08-04 | $214.30M 10-Q · filed 2013-08-06 | $343.90M derived: sum of 3 quarters · filed 2015-02-20 | $475.20M derived: sum of 4 quarters · filed 2015-02-20 | |||
| 2013-03-31 | $101.10M 10-Q · filed 2014-05-02 | $87.30M 10-Q · filed 2013-05-06 | $215.80M derived: sum of 2 quarters · filed 2015-02-20 | $347.10M derived: sum of 3 quarters · filed 2015-02-20 | $493.90M derived: sum of 4 quarters · filed 2015-02-20 | |||
| 2012-12-31 | $114.70M derived: 10-K 12 month − 10-Q 9 month · filed 2015-02-20 | $246.00M derived: sum of 2 quarters · filed 2015-02-20 | $392.80M derived: sum of 3 quarters · filed 2015-02-20 | $362.10M 10-K · filed 2015-02-20 | $373.80M 10-K · filed 2013-02-28 | |||
| 2012-09-30 | $131.30M derived: 10-Q 9 month − 10-Q 6 month · filed 2013-11-07 | $278.10M derived: sum of 2 quarters · filed 2013-11-07 | $247.40M 10-Q · filed 2013-11-07 | $340.80M derived: sum of 4 quarters · filed 2014-02-28 | ||||
| 2012-06-30 | $146.80M derived: 10-Q 6 month − 10-Q 3 month · filed 2013-08-06 | $116.10M 10-Q · filed 2013-08-06 | $209.50M derived: sum of 3 quarters · filed 2014-02-28 | $324.90M derived: sum of 4 quarters · filed 2014-02-28 | ||||
| 2012-03-31 | -$30.70M 10-Q · filed 2013-05-06 | $62.70M derived: sum of 2 quarters · filed 2014-02-28 | $178.10M derived: sum of 3 quarters · filed 2014-02-28 | $262.60M derived: sum of 4 quarters · filed 2014-02-28 | ||||
| 2011-12-31 | $93.40M derived: 10-K 12 month − 10-Q 9 month · filed 2014-02-28 | $208.80M derived: sum of 2 quarters · filed 2014-02-28 | $293.30M derived: sum of 3 quarters · filed 2014-02-28 | $308.20M 10-K · filed 2014-02-28 | $314.50M 10-K · filed 2012-02-27 | |||
| 2011-09-30 | $115.40M derived: 10-Q 9 month − 10-Q 6 month · filed 2012-11-07 | $199.90M derived: sum of 2 quarters · filed 2012-11-07 | $214.80M 10-Q · filed 2012-11-07 | $171.40M 10-Q · filed 2011-11-08 | $308.80M derived: sum of 4 quarters · filed 2013-02-28 | |||
| 2011-06-30 | $84.50M derived: 10-Q 6 month − 10-Q 3 month · filed 2012-08-07 | $99.40M 10-Q · filed 2012-08-07 | $193.40M derived: sum of 3 quarters · filed 2013-02-28 | |||||
| 2011-03-31 | $14.90M 10-Q · filed 2012-05-09 | $108.90M derived: sum of 2 quarters · filed 2013-02-28 | ||||||
| 2010-12-31 | $94.00M derived: 10-K 12 month − 10-Q 9 month · filed 2013-02-28 | $251.40M 10-K · filed 2013-02-28 | ||||||
| 2010-09-30 | $157.40M 10-Q · filed 2011-11-08 | |||||||
| 2009-12-31 | $165.30M 10-K · filed 2012-02-27 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| STERIS plc (STE) | Ireland | $20.343B | 25.49 |
| ZIMMER BIOMET HOLDINGS, INC. (ZBH) | United States | $17.103B | 20.66 |
| ALIGN TECHNOLOGY INC (ALGN) | United States | $10.346B | 29.06 |
| MSA Safety Inc (MSA) | United States | $7.023B | 21.47 |
| ESTABLISHMENT LABS HOLDINGS INC. (ESTA) | $1.954B | -65.76 | |
| Cadre Holdings, Inc. (CDRE) | United States | $1.123B | 33.88 |
| Enovis CORP (ENOV) | United States | $1.053B | -1.18 |
| Anteris Technologies Global Corp. (AVR) | United States | $0.746B | |
| Sanara MedTech Inc. (SMTI) | United States | $0.323B | -6.81 |
| Inogen Inc (INGN) | United States | $0.139B | -7.00 |